Pharmacogenomics

Pediatric septic shock treatment: new clues from genomic profiling
pp. 1287-1290(4)
Author: Wong, Hector R

Insulin gene mutations associated with neonatal diabetes
pp. 1291-1293(3)

Eyes on the prize: bringing individualized therapy from the bedside to clinical practice
pp. 1295-1298(4)
Author: Peters, J

Impact of population admixture on the distribution of the CYP3A5*3 polymorphism
pp. 1299-1306(8)
Authors: Suarez-Kurtz, Guilherme; Perini, Jamila A; Bastos-Rodrigues, Luciana; Pena, Sergio DJ; Struchiner, Cláudio

Combined glutathione S-transferase T1 and M1 positive genotypes afford protection against Type 2 diabetes in Japanese
pp. 1307-1314(8)
Authors: Hori, Masaharu; Oniki, Kentaro; Ueda, Kentaro; Goto, Shuji; Mihara, Shuichi; Marubayashi, Toru; Nakagawa, Kazuko

Expression of CYP2W1 in colon tumors: regulation by gene methylation
pp. 1315-1325(11)
Authors: Gomez, Alvin; Karlgren, Maria; Edler, David; Bernal, Maria Luisa; Mkrtchian, Souren; Ingelman-Sundberg, Magnus

Gene-gene and gene-environment interactions in interferon therapy for chronic hepatitis C
pp. 1327-1335(9)
Authors: Lin, Eugene; Hwang, Yuchi; Chen, Ellson Y

Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study
pp. 1337-1345(9)
Authors: Zhang, Aiping; Xing, Qinghe; Wang, Lei; Du, Jing; Yu, Lan; Lin, Zhiguang; Li, Xingwang; Feng, Guoyin; He, Lin

Effectiveness of in silico tagSNP selection methods: virtual analysis of the genotypes of pharmacogenetic genes
pp. 1347-1357(11)
Authors: Nam, Myung-Hyun; Won, Hong-Hee; Lee, Kyung-A; Kim, Jong-Won

Gene-expression microarrays provide new prognostic and predictive tests for breast cancer
pp. 1359-1368(10)
Authors: Gong, Yun; Symmans, W Fraser; Pusztai, Lajos

Genetic variation in the cytochrome P450 epoxygenase pathway and cardiovascular disease risk
pp. 1369-1383(15)
Authors: Theken, Katherine N; Lee, Craig R

Genetic variability in CYP2A6 and the pharmacokinetics of nicotine
pp. 1385-1402(18)
Authors: Mwenifumbo, Jill C; Tyndale, Rachel F

Clinical pharmacogenetics in pediatric patients
pp. 1403-1411(9)
Authors: Husain, Anwar; Loehle, Jennifer A; Hein, David W

Pharmacogenomics of platelet responsiveness to aspirin
pp. 1413-1425(13)
Authors: Faraday, Nauder; Becker, Diane M; Becker, Lewis C

Polymorphisms in the µ-opioid receptor gene (OPRM1) and the implications for alcohol dependence in humans
pp. 1427-1436(10)
Authors: van der Zwaluw, Carmen S; van den Wildenberg, Esther; Wiers, Reinout W; Franke, Barbara; Buitelaar, Jan; Scholte, Ron HJ; Engels, Rutger CME

Pyrosequencing for discovery and analysis of DNA sequence variations
pp. 1437-1441(5)
Authors: Ronaghi, Mostafa; Shokralla, Shadi; Gharizadeh, Baback

Limitations of pharmacogenomic predictor discovery in Phase II clinical trials
pp. 1443-1448(6)
Author: Pusztai, Lajos

Routine pharmacogenetic testing in clinical practice: dream or reality?
pp. 1449-1459(11)
Author: Grossman, Iris

Compugen, Ltd
pp. 1461-1463(3)
Author: Zangvil, Eli